Radiotherapy News and Research

RSS

Radiation therapy (in North America), or radiotherapy (in the UK and Australia) also called radiation oncology, and sometimes abbreviated to XRT, is the medical use of ionizing radiation as part of cancer treatment to control malignant cells (not to be confused with radiology, the use of radiation in medical imaging and diagnosis).

GEHC signs MOU with Concord Medical to form preferred strategic partnership in China

Concord Medical Services Holdings Limited, the operator of the largest network of radiotherapy and diagnostic imaging centers in China, today announced that it has signed an Memorandum of Understating with GE Healthcare, through its subsidiaries General Electric International Operations Company, Inc. and GE Medical Systems Trade & Development Co., Ltd., to form a preferred strategic partnership in China.

11 Aug 2011

A diet of flaxseed shows protective effects against radiation in mice

Flax has been part of human history for well over 30,000 years, used for weaving cloth, feeding people and animals, and even making paint. Now, researchers from the Perelman School of Medicine at the University of Pennsylvania have discovered that it might have a new use for the 21st century: protecting healthy tissues and organs from the harmful effects of radiation.

10 Aug 2011

Common culinary spice derivative could treat tendinitis

A derivative of a common culinary spice found in Indian curries could offer a new treatment hope for sufferers of the painful condition tendinitis, an international team of researchers has shown.

9 Aug 2011

Urine test for prostate cancer: Study

Lead researcher Dr. Scott Tomlins, a pathology resident at the University of Michigan Health System said, “This is a tool that men and their physician can use to help them decide whether it's appropriate to get a biopsy now or delay that decision.”

4 Aug 2011

Combination of six common QA measures could prevent radiotherapy errors

A combination of several well-known safety procedures could greatly reduce patient-harming errors in the use of radiation to treat cancer, according to a new study led by Johns Hopkins researchers.

3 Aug 2011

Valley Hospital Cancer Center selects RayStation for cutting edge technology

RaySearch Laboratories AB has received an order for its RayStation treatment planning system from The Valley Hospital Cancer Center in Paramus, New Jersey.

3 Aug 2011

Lipid nanocarriers in cancer diagnosis and therapy: New book

This book introduces fundamental principles of lipid nanocarriers science relevant to cancer therapy. The first in this field, it fills a need for an accurate, coherent and authoritative introduction to lipid nanocarriers focusing in cancer therapy; both because of the growing popularity of these modern drug delivery systems and also because of the emergent need of dealing with cancer treatment.

2 Aug 2011

Accuray to showcase CyberKnife, TomoTherapy systems at AAPM/COMP meeting

Accuray Incorporated, the premier radiation oncology company, announced today that it will showcase the CyberKnife Robotic Radiosurgery System and the TomoTherapy Radiation Therapy Treatment System in the company's booths at the 2011 Joint American Association of Physicists in Medicine (AAPM)/Canadian Organization of Medical Physicists (COMP) Meeting.

1 Aug 2011

Hormone therapy may be hazardous in men with pre-existing heart conditions

Adding hormone therapy to radiation therapy has been proven in randomized clinical trials to improve overall survival for men with intermediate- and high-risk prostate cancer. However, adding hormone therapy may reduce overall survival in men with pre-existing heart conditions, even if they have high-risk prostate cancer according to a new study just published online in advance of print in the International Journal of Radiation Oncology·Biology·Physics, the official scientific journal of ASTRO.

26 Jul 2011

Novalis Tx system for treatment of cancer goes into service today

A treatment system called the Novalis Tx has gone into service today, which has the ability to destroy cancerous cells virtually anywhere in the body in a single, 20-minute session, without the need for a single cut of the scalpel.

25 Jul 2011

Sirtex reports 4Q sales growth of 23%

Sirtex Medical Limited (ASX:SRX) today said sales of SIR-Spheres® microspheres, it’s targeted radioactive treatment for inoperable liver cancer, grew 23% in the fourth quarter of the 2011 Financial Year compared with the same quarter last year. Full year dose sales grew 19.3% compared to a 14% growth the year before.

21 Jul 2011

New anti-cancer drugs plus chemo for breast cancer shows promise: Study

Melbourne researchers have discovered that some of the most aggressive forms of cancers can be more effectively treated if chemotherapy is combined with a new class of anti-cancer drugs.

20 Jul 2011

CEL-SCI expands licensing agreement with Teva for Multikine cancer drug

CEL-SCI Corporation announced today that it has expanded the licensing agreement with Teva Pharmaceutical Industries Ltd. for its cancer drug Multikine.

20 Jul 2011

Drummond Group provides complete EMR certification for Varian's ARIA software for radiation oncology

Varian Medical Systems today announced its ARIA® software for electronic medical records (EMR) and clinical practice management in radiation oncology has been certified for clinics that can now use it to qualify for federal funding under the U.S. HITECH Act.

18 Jul 2011

CVS Caremark adds Access' MuGard to pharmacy benefit network

ACCESS PHARMACEUTICALS, INC., a biopharmaceutical company leveraging its proprietary drug-delivery platforms to develop treatments in areas of oncology, cancer supportive care and diabetes, announced that its lead product for oral mucositis, MuGard, has been added to CVS Caremark's pharmacy benefit network.

15 Jul 2011

Men with early-stage prostate cancer can benefit from short-term ADT, radiation therapy

Short-term hormone therapy given in combination with radiation therapy for men with early-stage prostate cancer increases their chance of living longer and not dying from the disease, compared with that of those who receive the same radiation therapy alone, according to a Radiation Therapy Oncology Group (RTOG) study published in the July 14 issue of the New England Journal of Medicine.

14 Jul 2011

UCI study sheds light on how transplantation alleviates side effects of radiotherapy

Human neural stem cells are capable of helping people regain learning and memory abilities lost due to radiation treatment for brain tumors, a UC Irvine study suggests.

14 Jul 2011

CMC hospital Ludhiana upgrades to MLCi2-equipped Elekta Compact linear accelerator

Christian Medical College & Hospital (CMC) Ludhiana is the site of the first Elekta Compact™ linear accelerator in the world to be field-upgraded to an MLCi2-equipped Elekta Compact, completing the transformation in less than a week. MLCi2 shapes treatment beams, enabling doctors to provide more accurate delivery to the target, while limiting radiation exposure to surrounding structures.

From Elekta 11 Jul 2011

FDA-approved Zuplenz oral soluble film now available for licensing to new commercial partners

MonoSol Rx, a specialty pharmaceutical company and the developers of the PharmFilm technology platform, in collaboration with APR Applied Pharma Research s.a. of Switzerland, announced today that its FDA-approved anti-emetic Zuplenz (Ondansetron) oral soluble film is available for licensing to new commercial partners.

11 Jul 2011

NewYork-Presbyterian Hospital offers two new treatment options for cancer patients

NewYork-Presbyterian Hospital has two new treatment options for patients with brain tumors and other cancers -- a next-generation radiosurgical Gamma Knife and linear accelerator.

From Elekta 11 Jul 2011